CGT

554개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved554 programs
CGTLimited DatastaleTaizhou HoudeAoke Biomedical Co…Phase 1

OH2 oncolytic virus (OH2 oncolytic virus)

Digestive System Neoplasms · Digestive System Neoplasms

#DigestiveSystemNeoplasms#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 14Status Active
CGTLimited DatastaleShanghai First Song Biotechnolo…Phase 1

Anti-CD30 CAR T cells (Anti-CD30 CAR T cells)

Adult T-Cell Lymphoma/Leukaemia; Anaplastic Large Cell Lymphoma · CD30

#CD30#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 13Status Active
CGTLimited DatastaleStephan Grupp MD PhDPhase 2

huCART19 (Autologous, humanized anti-CD19 CAR T cell therapy, Autologous, humanized anti-CD19 CAR T cell therapy (huCART19))

B-cell Acute Lymphoblastic Leukemia; B Lineage Lymphoblastic Lymphoma · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 13Status Recruiting
CGTAAVLimited DatastaleByron LamPhase 2

10e11 vg (Injection of AAV2-REP1, Injection of AAV2-REP1 (10e11 vg))

Choroideremia · Choroideremia

#Choroideremia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 13Status Active
CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

Anti-CD33 CAR T-cells (Anti-CD33 CAR T-cells)

Relapsed and/or Refractory Acute Myeloid Leukemia; High Risk Hematologic Malignancies · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 12Status Active
CGTLimited DatastaleBiohaven Pharmaceuticals, Inc.Phase 1

CIML-NK cell therapy (CIML-NK cell therapy)

Acute Myeloid Leukemia Refractory; Acute Myeloid Leukemia, in Relapse · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 12Status Recruiting
CGTLimited DatastaleShenzhen Institute for Innovati…Phase 2

Drugs and anti-CD19 CAR transduced T cells (Drugs and anti-CD19 CAR transduced T cells)

Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 12Status Active
CGTCurated CorestaleREGENXBIO Inc.Phase 2

RGX-314 (RGX-314)

Neovascular Age-related Macular Degeneration; Wet Age-related Macular Degeneration · Neovascular Age-related Macular Degenera

#NeovascularAge-relatedMacularDeg#CGT#Phase2#BioJungboMoa-pick#cell-gene-therapy+4
Trials 12Status Active
CGTLimited DatastaleKyverna TherapeuticsPhase 2

KYV-101 anti-CD19 CAR-T cell therapy (KYV-101 anti-CD19 CAR-T cell therapy)

Lupus Nephritis; Lupus Nephritis - WHO Class III · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 11Status Discontinued
CGTLimited DatastaleCARsgen Therapeutics Co., Ltd.Phase 1

anti-GPC3 CAR-T (anti-GPC3 CAR-T)

Advanced Hepatocellular Carcinoma · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 11Status Recruiting
CGTLimited DatastaleShenzhen Celconta Life Science …Phase 1

Claudin18.2-targeted CAR-T Cells (Claudin18.2-targeted CAR-T Cells)

Colorectal Neoplasia · Colorectal Neoplasia

#ColorectalNeoplasia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 10Status Recruiting
CGTLimited DatastaleChongqing University Cancer Hos…Phase 2

Oncolytic Virus H101 (Oncolytic Virus H101)

Rectal Neoplasms; Rectal Adenocarcinoma · Rectal Neoplasms

#RectalNeoplasms#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 10Status Recruiting
CGTLimited DatastaleNovartisPhase 1

huCART19 (huCART19)

Acute Lymphocytic Leukemia; Diffuse Large Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 10Status Active
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

huCART19 Cells (huCART19 Cells)

Chemotherapy Resistant Acute Lymphoblastic Leukemia; Refractory Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 10Status Recruiting
CGTLimited DatastaleMiltenyi Biomedicine GmbHPhase 2

MB-CART2019.1 (zamtocabtagene autoleucel, zamtocabtagene autoleucel (MB-CART2019.1))

Refractory Diffuse Large B Cell Lymphoma (DLBCL); Relapsed Diffuse Large B Cell Lymphoma · B-Cell Neoplasm

#B-CellNeoplasm#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 10Status Recruiting
CGTLimited DatastalePeproMene Bio, Inc.Phase 1

BAFFR-CAR T cells (BAFFR-CAR T cells)

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 9Status Recruiting
CGTLimited DatastaleChinese PLA General HospitalPhase 2

CART-EGFR (CART-EGFR)

Advanced EGFR-positive Solid Tumors · EGFR

#EGFR#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 9Status Active
CGTLimited DatastaleNanjing IASO Biotechnology Co.,…Phase 2

Eque-cel (Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection, Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (Eque-cel))

Relapsed/Refractory Multiple Myeloma · BCMA

#BCMA#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 9Status Recruiting
CGTAAVLimited DatastaleNovartis PharmaceuticalsPhase 2

Rapcabtagene autoleucel (Rapcabtagene autoleucel)

Idiopathic Inflammatory Myopathies · ANCA Associated Vasculitis (AAV)

#ANCAAssociatedVasculitisAAV#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 9Status Recruiting
CGTCurated CorestaleKitePhase 2

Tecartus (Tecartus)

Acute Lymphoblastic Leukemia; Large B-cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#BioJungboMoa-pick#cell-gene-therapy+4
Trials 9Status Recruiting

5 / 28 pages

← PreviousNext →